Cases & Deals

Bellicum Pharmaceuticals establishes global patent portfolio related to CAR-T and other cellular immunotherapies

Clients Bellicum Pharmaceuticals, Inc.

Jones Day is representing Bellicum Pharmaceuticals, Inc. in the development and prosecution of global patent portfolios related to cellular immuno-oncology (IO) and immunotherapies, including BPX-601 (PSCA CAR-T) and BPX-603 (Her2 CAR-T) clinical candidates utilizing the Bellicum’s proprietary GoCAR™ technology.